Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > DEEP POCKET JV NEEDED

<< Previous

Bullboard Posts

Next >>

Comment by menoalittleon Jul 23, 2024 1:15pm

164 Views

Post# 36144600

RE:RE:RE:DEEP POCKET JV NEEDED

Not a fan whatsover of that choice, and I would vote against it. Stock would end up a part of the ADR in the US (trading on the OTC) which pays a fee and the dividend yield, and only appears to yield 2.11%.

Merck, on the other hand, yields 2.47% and has significantly better opportunity for capital gains in addition to that. In other words, I'd be willing to take a fair bit less for stock swap with MRK.

<< Previous

Bullboard Posts

Next >>

A potential breakthrough in spinal cord and optic nerve injury treatment